Baillie Gifford & Co’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-432
Closed -$41.5K 340
2023
Q1
$41.5K Buy
432
+46
+12% +$4.26K ﹤0.01% 295
2022
Q4
$35.1K Hold
386
﹤0.01% 306
2022
Q3
$31K Hold
386
﹤0.01% 305
2022
Q2
$32K Buy
386
+21
+6% +$1.73K ﹤0.01% 307
2022
Q1
$30K Hold
365
﹤0.01% 318
2021
Q4
$27K Hold
365
﹤0.01% 341
2021
Q3
$28K Sell
365
-35
-9% -$2.71K ﹤0.01% 326
2021
Q2
$31K Hold
400
﹤0.01% 313
2021
Q1
$28K Buy
+400
New +$30.2K ﹤0.01% 304

Other funds holding DOX

Baillie Gifford & Co's DOX Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Amdocs (DOX) in Q2 2023, closing a stake of 432 shares — an estimated $41.5K sold.

Baillie Gifford & Co first reported a position in DOX in Q1 2021 and held it in 9 quarters. The position peaked at $41.5K in Q1 2023. 467 funds tracked by Wall St. Rank hold DOX as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Amdocs position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 432 Amdocs shares in Q2 2023, an estimated $41.5K.
  • Baillie Gifford & Co first reported a position in Amdocs in Q1 2021 and held it in 9 quarters.
  • Baillie Gifford & Co's Amdocs position peaked at $41.5K in Q1 2023.
  • 467 funds tracked by Wall St. Rank held Amdocs as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.